Alkem Laboratories has been issued ‘no 483s’ by the United States Food and Drug Administration (USFDA) for it Taloja facility. The USFDA has inspected the company’s Bioequivalence Facility at Taloja in state of Maharashtra from August 01 to August 10, 2016. At the end of the inspection, there were no 483s issued by the USFDA.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.
